108 related articles for article (PubMed ID: 8619446)
1. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status.
Kusaka M; Setiabudy R; Chiba K; Ishizaki T
Am J Trop Med Hyg; 1996 Feb; 54(2):189-96. PubMed ID: 8619446
[TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.
Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T
Br J Clin Pharmacol; 1995 Mar; 39(3):297-303. PubMed ID: 7619672
[TBL] [Abstract][Full Text] [Related]
3. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
[TBL] [Abstract][Full Text] [Related]
4. Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.
Basci NE; Bozkurt A; Kortunay S; Isimer A; Sayal A; Kayaalp SO
Br J Clin Pharmacol; 1996 Dec; 42(6):771-3. PubMed ID: 8971434
[TBL] [Abstract][Full Text] [Related]
5. Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography.
Taylor RB; Moody RR; Ochekpe NA
J Chromatogr; 1987 May; 416(2):394-9. PubMed ID: 3611272
[No Abstract] [Full Text] [Related]
6. The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism.
Kortunay S; Basci NE; Bozkurt A; Isimer A; Sayal A; Kayaalp SO
Eur J Clin Pharmacol; 1997; 53(3-4):261-4. PubMed ID: 9476042
[TBL] [Abstract][Full Text] [Related]
7. The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study.
Ward SA; Helsby NA; Skjelbo E; Brøsen K; Gram LF; Breckenridge AM
Br J Clin Pharmacol; 1991 Jun; 31(6):689-92. PubMed ID: 1867963
[TBL] [Abstract][Full Text] [Related]
8. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans.
Partovian C; Jacqz-Aigrain E; Keundjian A; Jaillon P; Funck-Brentano C
Clin Pharmacol Ther; 1995 Sep; 58(3):257-63. PubMed ID: 7554698
[TBL] [Abstract][Full Text] [Related]
9. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
Brøsen K; Skjelbo E; Flachs H
Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577
[TBL] [Abstract][Full Text] [Related]
10. Analysis of proguanil and its metabolites by application of the sweeping technique in micellar electrokinetic chromatography.
Taylor RB; Reid RG; Low AS
J Chromatogr A; 2001 May; 916(1-2):201-6. PubMed ID: 11382292
[TBL] [Abstract][Full Text] [Related]
11. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
[TBL] [Abstract][Full Text] [Related]
12. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.
Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB
Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239
[TBL] [Abstract][Full Text] [Related]
13. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
Coller JK; Somogyi AA; Bochner F
Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
[TBL] [Abstract][Full Text] [Related]
14. Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography.
Bergqvist Y; Funding L; Krysèn B; Leek T; Yvell K
Ther Drug Monit; 1998 Jun; 20(3):325-30. PubMed ID: 9631931
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous high-performance liquid chromatography-electrochemical detection determination of imipramine, desipramine, their 2-hydroxylated metabolites, and imipramine N-oxide in human plasma and urine: preliminary application to oxidation pharmacogenetics.
Koyama E; Kikuchi Y; Echizen H; Chiba K; Ishizaki T
Ther Drug Monit; 1993 Jun; 15(3):224-35. PubMed ID: 8333003
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of proguanil: a probe phenotyping drug for the mephenytoin hydroxylase polymorphism.
Somogyi AA; Reinhard HA; Bochner F
Br J Clin Pharmacol; 1996 Mar; 41(3):175-9. PubMed ID: 8866915
[TBL] [Abstract][Full Text] [Related]
17. Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography-mass spectrometry.
Leveque NL; Charman WN; Chiu FC
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):314-21. PubMed ID: 16310420
[TBL] [Abstract][Full Text] [Related]
18. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
[TBL] [Abstract][Full Text] [Related]
19. Metabolic disposition of lansoprazole in relation to the S-mephenytoin 4'-hydroxylation phenotype status.
Sohn DR; Kwon JT; Kim HK; Ishizaki T
Clin Pharmacol Ther; 1997 May; 61(5):574-82. PubMed ID: 9164419
[TBL] [Abstract][Full Text] [Related]
20. [Determination of mephenytoin and 4'-hydroxymephenytoin in urine by high performance liquid chromatography].
Ruan ZR; Cheng YS; Ding DY
Yao Xue Xue Bao; 1994; 29(8):624-8. PubMed ID: 7985520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
